Identification of N-{cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for the Treatment of Autoimmune Diseases. (Q48316535)
Jump to navigation
Jump to search
scientific article published on 3 January 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Identification of N-{cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for the Treatment of Autoimmune Diseases. |
scientific article published on 3 January 2018 |
Statements
Identification of N-{cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for the Treatment of Autoimmune Diseases (English)
Neelu Kaila
Joseph W Strohbach
John D Trzupek
Matthew F Brown
Mark E Flanagan
Timothy A Johnson
Ruth E TenBrink
Eric P Arnold
Arindrajit Basak
Steven E Heasley
Soojin Kwon
Jonathan Langille
Mihir D Parikh
Sarah H Griffin
Jeffrey M Casavant
Brian A Duclos
Ashley E Fenwick
Thomas M Harris
Seungil Han
Nicole Caspers
Martin E Dowty
Xin Yang
Mary Ellen Banker
Martin Hegen
Peter T Symanowicz
Li Li
Lu Wang
Tsung H Lin
Jason Jussif
James D Clark
Jean-Baptiste Telliez